Skip to content
grad
Clinical Trials Portal

Clinical Trials Portal

Bon Secours Richmond Health System

  • Home
  • FAQs

Author: Terrance Jackson

Alliance Alchemist E4512

A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Read more about this trial →

← Back to available clinical trials

S1900B

A Phase II Study of Selpercatinib (LOXO-292) in Patients with RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer

 

 

 

 

Read more about this trial →

← Back to available clinical trials

S1802

Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer.”

Read more about this trial →

← Back to available clinical trials

Swog 1714

http://http://www.ClinicalTrials.govA Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients

Read more about this trial →

← Back to available clinical trials

A191901

Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions,”

Read more about this trial →

← Back to available clinical trials

EA2186

A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer

Read more about this trial →

← Back to available clinical trials

EAZ171

Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women

Read more about this trial →

← Back to available clinical trials

A011801

The CompassHER2 trials (COMprehensive use of Pathologic Response ASSessment to optimize therapy in HER2-positive breast cancer): CompassHER2 Residual Disease (RD), a double-blinded, phase III randomized trial of T-DM1 and placebo compared with T-DM1 and tucatinib

Read more about this trial →

← Back to available clinical trials

A171901

Older Non-Small Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy

Read more about this trial →

← Back to available clinical trials

Want to Know More?

Our Department participates in the National Cancer Institute Community Oncology Research  Program (NCORP). We are currently the top accruing site for treatment trials within our NCORP. We would not be able to hold this achievement without each of our patients and our hard work is a testament to them!

Check out these informational videos provided by the National Cancer Institute to learn more about Clinical Research.

APPOINTMENTS AVAILABLE

To inquire about participation in a clinical trial, please contact us by phone at (804) 893-8717 or by email at rvaoncologyresearch@bshsi.org

See our FAQs

logo

logo logo

Bon Secours International | Sisters of Bon Secours USA | Bon Secours Health System
This page is managed by the Bon Secours Richmond Health System in Richmond, VA.
© 2017 Bon Secours Health System, Inc.

  • Yelp
  • Facebook
  • Twitter
  • Instagram
  • Email
Proudly powered by WordPress